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cytokines such as IL­8, IL­6, and IL­11 
(Molet et al., 2001). These IL­17 activi­
ties could promote tissue fibrosis, chro­
nicity of the inflammatory process, and 
the evolution of chronic inflammatory 
cutaneous lesions. However, Koga et 
al. (2008) demonstrated lower levels of 
IL­17 during the chronic phase of AD, 
suggesting a possible Th17­to­Th1 shift 
in later phases of the disease. Their find­
ings suggest a link between innate and 
acquired immunity in allergy, highlight­
ing the relevance of balanced and recip­
rocal interaction among Th1, Th2, and 
Th17 cells in inflammation. Further stud­
ies are needed to clarify the role of Th17 
cells in the pathogenesis of AD, especial­
ly identification of the stage of the dis­
ease in which Th17 might play a role.
It will also be interesting to deter­
mine why, despite the presence of 
Th17 cells, there are no prominent 
neutrophilic infiltrates and no efficient 
protection against extracellular patho­
gens such as Staphylococcus aureus in 
AD. Th17 cells have been proposed to 
lead to neutrophil infiltration as a result 
of the production of IL­22 and IL­17A 
and the induction of IL­8 and anti­
microbial peptides in epithelial cells. 
This cascade may have pathological 
relevance both in asthma and in psori­
asis. Psoriasis and late­phase AD share 
many pathologic features, such as epi­
thelial hyperplasia, abnormal differen­
tiation of keratinocytes, and prominent 
T­lymphocyte and dendritic cell infil­
tration. Nevertheless, they have always 
been considered contrasting poles of 
immunopathologies because of the 
dichotomy of Th cells (Th2 versus Th1) 
and the presence of different subsets of 
leukocytes (eosinophils versus neutro­
phils) and dendritic cells. The presence 
of Th17 cells, in addition to Th1 cells, 
in AD provides a basis for a common 
effector pathway in AD and psoriasis, 
and this could partially explain some 
of their clinicopathologic similarities. 
Ultimately, this suggests that these 
inflammatory skin disorders might have 
common therapeutic targets.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENT
A.D.C. and P.D.M. contributed equally  
to this work.
See related article on pg 2686
notch and Melanocytes: Diverse 
Outcomes from a single signal
Masatake Osawa1 and David E. Fisher1,2,3
notch signaling is an evolutionally conserved pathway that serves as a critical 
regulator of cell fate. From a series of studies, including a report in this issue, 
researchers have begun to elucidate the critical functions of notch signaling in 
the regulation of melanocyte lineage development. With evidence of a recent-
ly identified role for notch signaling in melanomagenesis, characterization of 
downstream molecular events may offer potential avenues for the development 
of novel therapeutic strategies.
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Single signal, diverse outcomes: a critical 
question in developmental biology
Tissue organogenesis is governed by 
a remarkably small set of evolution­
ally conserved signaling pathways. 
These signals, which may be termed 
a “developmental toolkit,” include 
the BMP, FGF, Notch, Hedgehog, and 
Wnt signaling pathways (Canestro et 
al., 2007). During development, these 
toolkit signaling pathways are utilized 
in a diverse range of discrete cell lin­
eages in a spaciotemporally regulat­
ed manner to build a wide variety of 
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morphologically and functionally dis­
tinct tissues. One central question in 
developmental biology is how such a 
small number of toolkit pathways can 
generate the huge diversity seen in tis­
sue development. To accomplish this 
diversity, the signals appear to engage 
in cross­talk with other signaling path­
ways, allowing them to be integrated 
into a network of large signaling com­
plexes, which may generate diversity 
from individual signaling events. The 
genome sequencing project has helped 
to identify each component in the sig­
naling networks. Researchers in the 
postgenomic era are trying to “con­
nect the dots” to understand how net­
works interact. Such efforts will lead to 
a more comprehensive understanding 
of signaling networks and the mainte­
nance of healthy homeostasis. Because 
disruption of these networks may be 
pathogenic, a detailed understanding of 
these signaling effects may have broad 
implications, not only for developmen­
tal biology but also for the discovery of 
novel therapeutic strategies.
notch signaling and  
its functional versatility
Notch compromises a family of evo­
lutionarily conserved receptors whose 
activation is mediated by specific cell–
cell interaction with cells expressing 
the ligands Jagged or Delta (Artavanis­
Tsakonas et al., 1999). Upon activa­
tion, the intracellular domain of the 
Notch receptor is cleaved and trans­
located into the nucleus to generate a 
transactivation complex with the RBP­J 
transcription factor. The resulting com­
plex initiates transactivation of vari­
ous target genes, including the hairy/
enhancer of split (Hes) transcriptional 
repressors (Artavanis­Tsakonas et al., 
1999). The Hes family repressor repre­
sents a bona fide target of Notch sig­
naling and plays a central role down­
stream in the Notch pathway. Hes fam­
ily repressors antagonize the expres­
sion of a wide variety of activator­type 
bHLH transcription factors, including 
Ascl1, Atoh1, and Neurog3, which 
is critical for maintaining cells in an 
undifferentiated state (Kageyama et al., 
2007). In addition to this canonical 
pathway, an RBP­J­independent nonca­
nonical pathway and a Hes­independent 
signaling pathway also play important 
roles downstream of Notch signaling, 
although the exact molecular events 
mediating these noncanonical pathways 
are less fully characterized.
Despite a considerable understand­
ing of signal transduction by Notch, its 
outcomes are complex. One impor­
tant feature of Notch signaling is that 
the outcome of this pathway is highly 
dependent on cell context. This could 
be partly explained by its ability to 
cross­talk with diverse signaling path­
ways (Hurlbut et al., 2007). In fact, it 
has been demonstrated that Notch sig­
naling may indeed undergo cross­talk 
with nearly all components of the devel­
opmental toolkit (Hurlbut et al., 2007). 
Accumulating evidence indicates 
pleiotropic roles for Notch signaling 
in diverse cellular processes, including 
cell cycle arrest regulation, apoptosis/
survival, differentiation, and stem cell 
maintenance. Moreover, recent stud­
ies have revealed cross­talk between 
Notch signaling and the hypoxia 
response (Gustafsson et al., 2005). 
Given that many diverse cellular pro­
cesses may need to be accompanied 
by regulation of cellular metabolism 
(or, conversely, that metabolic changes 
may require compensatory changes in 
diverse cellular pathways), it may be 
notably efficient that Notch signaling 
simultaneously regulates these distinct 
cellular events. An obvious question 
arises: how can Notch signaling mech­
anistically accomplish these versatile 
functions?
One fresh insight has been obtained 
from a recent analysis of epider­
mal development (Moriyama et al., 
2008). In epidermal development, 
Notch signaling induces granular cell 
differentiation from spinous cells but 
simultaneously prevents premature dif­
ferentiation of spinous cells (Moriyama 
et al., 2008). In this setting, Notch sig­
naling through the RBP­J transactivator 
directly promotes expression of the 
Ascl2 bHLH transcription factor, which 
is responsible for induction of granular 
differentiation. On the other hand, 
Notch signaling through the Hes1 
repressor simultaneously suppresses 
Ascl2 expression by interfering with the 
RBP­J­mediated transactivation func­
tion, which is essential for maintaining 
the undifferentiated status of spinous 
cells (Moriyama et al., 2008). These 
findings indicate that, in addition to an 
ability to cross­talk with various signal­
ing pathways, the simultaneous exis­
tence of both a transcriptional activator 
and a repressor downstream of Notch 
signaling may play an important role in 
the versatile functions of Notch signal­
ing. More detailed studies may help to 
determine how Notch signaling con­
trols these outcomes.
notch signaling  
in the melanocyte lineage
During development, melanoblasts—
the precursors of pigmented mel­
anocytes—arise in the neural crest 
and migrate through the epidermis to 
newly forming hair follicles. Once in 
the follicle, they eventually segregate 
into two populations: melanocyte 
stem cells, which colonize the lower 
permanent portion of the hair follicle 
(the bulge region) and maintain the 
hair pigmentary unit for subsequent 
hair cycles, and differentiated mel­
anocytes in the hair matrix (the bulb 
region), responsible for pigmentation 
of the growing hairs. In non­hairy 
regions, melanocytes reside deep in 
the epidermis (near the dermal/epider­
mal junction), where they respond to 
differentiation/pigmentation cues from 
surrounding keratinocytes or other 
environmental signals.
It has been widely accepted that 
significant homeostatic regulation of 
melano cytes may occur through cell–
cell interactions between keratinocytes 
and melanocytes (Hirobe, 2005), where­
as the underlying molecular mecha­
nisms are incompletely understood. 
A series of recent studies elucidated 
Notch signaling as a key component 
among keratinocyte–melanocyte inter­
actions (Kumano et al., 2008; Moriyama 
et al., 2006; Schouwey et al., 2007). 
Now Aubin­Houzelstein et al. (2008, 
this issue) extend these studies and add 
several new implications for the func­
tion of Notch signaling in regulation of 
the melanocyte lineage within the hair 
follicle.
Notch signaling plays an indispens­
able role in the maintenance of mel­
anoblasts and melanocyte stem cells of 
the epidermis (Moriyama et al., 2006; 
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Schouwey et al., 2007). Genetic abla­
tion of Notch signaling in the mouse 
results in a dramatic reduction of 
embryonic melanoblasts (via apopto­
sis), which manifests itself as dilution 
of initial hair pigmentation (Moriyama 
et al., 2006; Schouwey et al., 2007). 
These animals also exhibit premature 
hair graying in subsequent hair cycles, 
suggesting an important role for Notch 
signaling in the maintenance of mel­
anocyte stem cells (Moriyama et al., 
2006; Schouwey et al., 2007). The latter 
function of Notch signaling has recent­
ly been further supported by the phar­
macologic inhibition of Notch signaling 
in adult mice (Kumano et al., 2008). 
In this issue, Aubin­Houzelstein et al. 
describe their use of an elegant in vivo 
marking technique to examine how loss 
of Notch signaling affects the behavior 
of follicular melanocytes/melanoblasts. 
This permitted the investigators to iden­
tify several previously unrecognized 
abnormalities within the follicular mel­
anocyte lineage, including premature 
differentiation and mislocalization of 
melanoblasts and abnormal differentia­
tion of hair matrix melanocytes. These 
findings indicate that, in addition to 
mainten ance of melano blasts and mel­
anocyte stem cells, Notch signaling 
plays roles in maintaining the imma­
ture status of melanoblasts, promoting 
proper localization of melanoblasts, 
and inducing proper melanocyte 
differentiation in the hair matrix (Aubin­
Houzelstein et al., 2008). The premature 
differentiation phenotype of Notch­
deficient melanoblasts is reminiscent 
of Mitfvit/vit mutant mice, a mild hypo­
morphic mutation in the gene encoding 
the Mitf transcription factor (Nishimura 
et al., 2005). These similarities suggest 
a link between Notch signaling and 
Mitf in the regulation of melanoblasts 
or melano cyte stem cells, although a 
direct mechanistic link has not yet been 
identified and the phenotypes could 
alternatively reflect common down­
stream effects from interfering with 
these different factors.
Several interesting questions remain 
unsolved. Why did only a proportion 
of melanoblasts (~13%) undergo dif­
ferentiation, leaving many melanoblasts 
(~77%) immature? This incomplete 
penetrance could reflect the presence 
of discrete melanocytic subpopulations 
that were heretofore unrecognized 
(unless the effect is due to varied com­
pleteness of allele knockout). Second, 
why did Notch­deficient melanocytes 
differentiate normally in the initial 
hairs but not in the second hair cycle? 
Given the dramatic reduction of embry­
onic melanoblasts, it may be useful to 
consider the possibility that certain 
abnormal phenotypes in the postnatal 
hair follicles might be related to sec­
ondary or unexpected consequences 
of embryonic melanoblast reduction. 
Alternatively, it is possible that signaling 
requirements for the first cycle vary in 
certain mechanistic ways relative to sub­
sequent cycles. Regardless, the interest­
ing studies of Aubin­Houzelstein et al. 
(2008) should trigger additional experi­
ments utilizing postnatal inducible loss­
of­function strategies, such as the use of 
Tyr-CreER transgenic mice (Bosenberg 
et al., 2006; Yajima et al., 2006), to 
define precise functions of Notch sig­
naling at discrete developmental stages 
in the melanocyte lineage.
Future directions
Notch signaling is an essential compo­
nent of epidermal–melanocyte interac­
tions. Why do epidermal melanocytes 
require Notch signaling? One possible 
clue is provided by Schouwey et al. 
(2007), who demonstrate that epider­
mal melanocytes are eliminated in 
the melanocyte­specific Notch1 and 
Notch2 double­deficient mice, where­
as dermal and choroidal melanocytes 
are left intact. This result suggests that 
Notch signaling is not required for 
nonepidermal melanocytes. Given the 
common origin of epidermal and non­
epidermal melanocytes, one possible 
explanation for this is that Notch signal­
ing may be required to adapt melano­
blasts to the epidermal environment. In 
this regard, it may be noteworthy that 
the epidermis is thought to be more 
consistently hypoxic compared with 
the dermis. Considering the potential 
cross­talk between Notch signaling and 
the hypoxia response, it is possible that 
Notch signaling may provide hypoxia 
adaptation selectively to epidermal 
melanoblasts.
Melanocytes afford an advantageous 
model in which to define survival 
pathway interactions, because genet­
ic alterations controlling melanocyte 
viability are easily identifiable by coat 
color phenotypes that do not affect 
the viability of the animal. Hence, by 
integrating combinatory gene knock­
out approaches and phenotype­based 
screening systems, melanocytes can 
provide an invaluable tool to identify 
molecules that interact with Notch sig­
naling. This approach has already been 
validated. The premature­hair­graying 
phenotype of Bcl2 knockout mice is 
rescued in Bcl2–/–; Bim–/– double­knock­
out mice (Bouillet et al., 2001), reveal­
ing a striking molecular link between 
Bcl2 and Bim. Relative to Notch sig­
naling, Kumano et al. (2008) reported 
premature hair graying in Notch1–/+; 
Notch2–/+; W v/+ mice, indicating a pos­
sibility of cross­talk between Notch and 
c­Kit signaling in regulation of the mel­
anocyte lineage.
Because melanomas emerge primar­
ily within epidermal melanoblasts or 
melanocytes, it is reasonable to specu­
late that both normal and malignant 
melanoblasts may share key pathways 
that regulate biological homeostasis and 
maintenance. These similarities include 
the epithelial–mesenchymal transition 
and an invasive/migratory capacity that 
is central to both normal and malig­
nant cells of the melanocyte lineage. 
Interestingly, it was recently demon­
strated that, as in normal melanoblast 
development, Notch signaling partici­
pates in melanoma progression (Balint 
et al., 2005; Liu et al., 2006). Thus, the 
elucidation of molecular mechanisms 
downstream of Notch is important not 
only for melanoblast development but 
also for understanding the molecular 
mechanisms of melanomagenesis.
Returning to the original question of 
how small numbers of signals produce 
great biological diversity, the fact that 
Notch signaling is now implicated in 
|Notch signaling plays multiple roles in the melanocyte lineage.
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multiple distinct melanocyte pathways 
should provide both a clue and an 
opportunity. Because the melanocyte 
system permits genetic alteration with­
out loss of mouse viability, the pigmen­
tary phenotype can be deeply probed in 
order to identify the “dots” that connect 
Notch to its interacting signaling path­
ways. These efforts should ultimately 
reveal a fascinating network, which 
may provide answers pertinent for 
other developmental lineages, as well 
as clues for novel therapeutics aimed at 
melanocytic malignancy.
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